Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biostruggle who wrote (3061)	8/14/2002 12:01:39 PM
From: Harold Engstrom	Read Replies (1) of 10345

I concur. Furthermore, at the moment, Myobloc accounts for a very small percentage of revenues. And we don't have enough information to know whether margins are an issue at all for myobloc. Bill, things are probably not as bleak as your would paint them. The company has revenue from product sales. $1B worth. The company has IP and business units and sales forces and more. While things are riskier than would could have anticipated, there is a very good chance that Elan can pull out of this and climb strongly - it needs to execute on stated plan and it needs good trial results news. Now the company is not an underpriced, fully-integrated pharmaceutical company; it is an company trying to become a fully-integrated biopharmaceutical company again.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next